We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+27.79%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$7.1B
AUM Growth
+$4.71B
Cap. Flow
+$3.74B
Cap. Flow %
52.72%
Top 10 Hldgs %
42.13%
Holding
1,020
New
424
Increased
501
Reduced
44
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 24.57%
2 Financials 13.35%
3 Energy 3.93%
4 Healthcare 3.4%
5 Real Estate 3.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVZ icon
501
Invesco
IVZ
$13.1B
$1.16M 0.02%
107,388
+92,286
+611% +$828K
COR
502
DELISTED
Coresite Realty Corporation
COR
$1.15M 0.02%
+9,493
New +$1.14M
ASB icon
503
Associated Banc-Corp
ASB
$5.83B
$1.15M 0.02%
+83,742
New +$1.14M
REXR icon
504
Rexford Industrial Realty
REXR
$8.42B
$1.14M 0.02%
+27,580
New +$1.11M
ACC
505
DELISTED
American Campus Communities, Inc.
ACC
$1.14M 0.02%
+32,628
New +$1.08M
BLDR icon
506
Builders FirstSource
BLDR
$7.15B
$1.13M 0.02%
+54,796
New +$990K
ALKS icon
507
Alkermes
ALKS
$8.22B
$1.13M 0.02%
58,383
+41,444
+245% +$673K
BSX icon
508
Boston Scientific
BSX
$69.5B
$1.13M 0.02%
32,102
+21,377
+199% +$770K
ESPR
509
DELISTED
Esperion Therapeutics
ESPR
$1.13M 0.02%
+21,960
New +$919K
HALO icon
510
Halozyme
HALO
$9.79B
$1.12M 0.02%
+41,845
New +$944K
CRWD icon
511
CrowdStrike
CRWD
$194B
$1.11M 0.02%
+44,308
New +$888K
INSG icon
512
Inseego
INSG
$114M
$1.11M 0.02%
+9,571
New +$1.01M
SLG icon
513
SL Green Realty
SLG
$3.76B
$1.11M 0.02%
23,228
+15,723
+210% +$722K
JNPR
514
DELISTED
Juniper Networks
JNPR
$1.1M 0.02%
48,253
+36,236
+302% +$834K
RARE icon
515
Ultragenyx Pharmaceutical
RARE
$2.45B
$1.1M 0.02%
14,033
+7,335
+110% +$485K
RGA icon
516
Reinsurance Group of America
RGA
$15.5B
$1.1M 0.02%
+13,983
New +$1.29M
SAGE
517
DELISTED
Sage Therapeutics
SAGE
$1.1M 0.02%
+26,379
New +$957K
IMMU
518
DELISTED
Immunomedics Inc
IMMU
$1.09M 0.02%
30,876
+10,933
+55% +$320K
BBIO icon
519
BridgeBio Pharma
BBIO
$15.7B
$1.09M 0.02%
+33,309
New +$1.01M
AGIO icon
520
Agios Pharmaceuticals
AGIO
$1.79B
$1.08M 0.02%
20,257
+13,251
+189% +$614K
KPTI icon
521
Karyopharm Therapeutics
KPTI
$43.5M
$1.08M 0.02%
3,812
+2,984
+360% +$883K
TGTX icon
522
TG Therapeutics
TGTX
$7.96B
$1.08M 0.02%
55,557
+44,830
+418% +$722K
FAF icon
523
First American
FAF
$7.66B
$1.07M 0.02%
+22,328
New +$1.05M
BPMC
524
DELISTED
Blueprint Medicines
BPMC
$1.07M 0.02%
13,664
+8,309
+155% +$562K
FATE icon
525
Fate Therapeutics
FATE
$286M
$1.07M 0.02%
+31,065
New +$926K

Similar funds

Rafferty Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Rafferty Asset Management held 1,020 positions worth $7.1B, up 197% from $2.39B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Rafferty Asset Management deployed $3.74B of net new capital in Q2 2020, opening 424 new positions and adding to 501 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 3,402,773 shares worth $178M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 18% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was VanEck Junior Gold Miners ETF, an estimated $266M trimmed.

  • Rafferty Asset Management's largest Q2 2020 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 3,402,773 shares worth $178M.
  • Rafferty Asset Management added most to iShares Russell 2000 ETF in Q2 2020, an estimated $529M increase.
  • Rafferty Asset Management's biggest Q2 2020 reduction was VanEck Junior Gold Miners ETF, cutting an estimated $266M.
  • Rafferty Asset Management fully exited Cable One in Q2 2020, selling an estimated $2.84M.
  • Rafferty Asset Management's ten largest holdings make up 42% of its $7.1B portfolio in Q2 2020.
  • Rafferty Asset Management opened 424 new positions and closed 50 in Q2 2020.
  • Rafferty Asset Management's portfolio value rose 197% quarter-over-quarter to $7.1B.

Based on Rafferty Asset Management's 13F filing for Q2 2020, filed 7 Aug 2020.